These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 22718130)

  • 21. Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax.
    Albrecht MT; Li H; Williamson ED; LeButt CS; Flick-Smith HC; Quinn CP; Westra H; Galloway D; Mateczun A; Goldman S; Groen H; Baillie LW
    Infect Immun; 2007 Nov; 75(11):5425-33. PubMed ID: 17646360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monitoring of ELISA-reactive antibodies against anthrax protective antigen (PA), lethal factor (LF), and toxin-neutralising antibodies in serum of individuals vaccinated against anthrax with the PA-based UK anthrax vaccine.
    Grunow R; Porsch-Ozcürümez M; Splettstoesser W; Buckendahl A; Hahn U; Beyer W; Böhm R; Huber M; vd Esche U; Bessler W; Frangoulidis D; Finke EJ
    Vaccine; 2007 May; 25(18):3679-83. PubMed ID: 17287051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits.
    Wimer-Mackin S; Hinchcliffe M; Petrie CR; Warwood SJ; Tino WT; Williams MS; Stenz JP; Cheff A; Richardson C
    Vaccine; 2006 May; 24(18):3953-63. PubMed ID: 16530302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of protective antigen, an anthrax specific toxin in human serum by using surface plasmon resonance.
    Ghosh N; Gupta N; Gupta G; Boopathi M; Pal V; Goel AK
    Diagn Microbiol Infect Dis; 2013 Sep; 77(1):14-9. PubMed ID: 23773677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a multiple-antigen protein fusion vaccine candidate that confers protection against Bacillus anthracis and Yersinia pestis.
    Gallagher TB; Mellado-Sanchez G; Jorgensen AL; Moore S; Nataro JP; Pasetti MF; Baillie LW
    PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007644. PubMed ID: 31430284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of immune response to orally administered Sterne strain 34F2 anthrax vaccine.
    Shakya KP; Hugh-Jones ME; Elzer PH
    Vaccine; 2007 Jul; 25(29):5374-7. PubMed ID: 17555849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anthrax Vaccine Precipitated Induces Edema Toxin-Neutralizing, Edema Factor-Specific Antibodies in Human Recipients.
    Dumas EK; Gross T; Larabee J; Pate L; Cuthbertson H; Charlton S; Hallis B; Engler RJM; Collins LC; Spooner CE; Chen H; Ballard J; James JA; Farris AD
    Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28877928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of Bacillus anthracis extractable antigen for testing anthrax immunity.
    Shlyakhov E; Shoenfeld Y; Gilburd B; Rubinstein E
    Clin Microbiol Infect; 2004 May; 10(5):421-4. PubMed ID: 15113319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. mAbs to Bacillus anthracis capsular antigen for immunoprotection in anthrax and detection of antigenemia.
    Kozel TR; Murphy WJ; Brandt S; Blazar BR; Lovchik JA; Thorkildson P; Percival A; Lyons CR
    Proc Natl Acad Sci U S A; 2004 Apr; 101(14):5042-7. PubMed ID: 15051894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid homogenous time-resolved fluorescence (HTRF) immunoassay for anthrax detection.
    Cohen N; Mechaly A; Mazor O; Fisher M; Zahavy E
    J Fluoresc; 2014 May; 24(3):795-801. PubMed ID: 24515915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of enzyme-linked immunosorbent and indirect hemagglutination assays for determining anthrax antibodies.
    Johnson-Winegar A
    J Clin Microbiol; 1984 Sep; 20(3):357-61. PubMed ID: 6436303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BA3338, a surface layer homology domain possessing protein augments immune response and protection efficacy of protective antigen against Bacillus anthracis in mouse model.
    Kumar M; Puranik N; Varshney A; Tripathi N; Pal V; Goel AK
    J Appl Microbiol; 2020 Aug; 129(2):443-452. PubMed ID: 32118336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of anthrax infection with combination of ciprofloxacin and antibodies to protective antigen of Bacillus anthracis.
    Karginov VA; Robinson TM; Riemenschneider J; Golding B; Kennedy M; Shiloach J; Alibek K
    FEMS Immunol Med Microbiol; 2004 Jan; 40(1):71-4. PubMed ID: 14734189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toxin-neutralizing antibodies elicited by naturally acquired cutaneous anthrax are elevated following severe disease and appear to target conformational epitopes.
    Dumas EK; Demiraslan H; Ingram RJ; Sparks RM; Muns E; Zamora A; Larabee J; Garman L; Ballard JD; Boons GJ; James JA; Kayabas U; Doganay M; Farris AD
    PLoS One; 2020; 15(4):e0230782. PubMed ID: 32294093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of nasal immunization with protective antigen of Bacillus anthracis on protective immune response against anthrax toxin.
    Gaur R; Gupta PK; Banerjea AC; Singh Y
    Vaccine; 2002 Jun; 20(21-22):2836-9. PubMed ID: 12034111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Select human anthrax protective antigen epitope-specific antibodies provide protection from lethal toxin challenge.
    Crowe SR; Ash LL; Engler RJ; Ballard JD; Harley JB; Farris AD; James JA
    J Infect Dis; 2010 Jul; 202(2):251-60. PubMed ID: 20533877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of a vaccine based on protective antigen and killed spores against experimental inhalational anthrax.
    Gauthier YP; Tournier JN; Paucod JC; Corre JP; Mock M; Goossens PL; Vidal DR
    Infect Immun; 2009 Mar; 77(3):1197-207. PubMed ID: 19114543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enzyme-linked immunosorbent assay for detection of immunoglobulin G antibodies to Escherichia coli Vero cytotoxin 1.
    Karmali MA; Petric M; Winkler M; Bielaszewska M; Brunton J; van de Kar N; Morooka T; Nair GB; Richardson SE; Arbus GS
    J Clin Microbiol; 1994 Jun; 32(6):1457-63. PubMed ID: 8077389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anthrax capsule vaccine protects against experimental infection.
    Chabot DJ; Scorpio A; Tobery SA; Little SF; Norris SL; Friedlander AM
    Vaccine; 2004 Nov; 23(1):43-7. PubMed ID: 15519706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Qualification and performance characteristics of a quantitative enzyme-linked immunosorbent assay for human lgG antibodies to anthrax lethal factor antigen.
    Selinsky CL; Whitlow VD; Smith LR; Kaslow DC; Horton HM
    Biologicals; 2007 Apr; 35(2):123-9. PubMed ID: 17071101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.